Alkermes (ALKS) Return on Invested Capital (2011 - 2026)
Alkermes (ALKS) posted quarterly Return on Invested Capital of 0.02% for Q2 2026, down 69.0% year-over-year from 0.06% in Q2 2025, and down 97.16% quarter-over-quarter from 0.71% in Q2 2025.
Alkermes (ALKS) Return on Invested Capital (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Return on Invested Capital for 16 consecutive years, with 0.02% the latest figure, recorded in Q2 2026.
- In Q2 2026, Return on Invested Capital fell 69.0% year-over-year to 0.02%; the TTM figure through Jun 2026 stood at 0.02% (down 69.0% YoY), while the FY2023 annual figure was 1.7%, up 173.0% from the prior year.
- Return on Invested Capital eased to 0.02% in Q2 2026 per ALKS's latest filing, from 0.71% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.71% in Q2 2025 and bottomed at 0.06% in Q1 2023.
- Historically, Return on Invested Capital has averaged 0.25% across 5 years, with a median of 0.3% in 2024.
- Annual changes were most pronounced in 2024 — Return on Invested Capital jumped 52 bps — and 2026, when it sank 69 bps.
- Alkermes' Return on Invested Capital stood at 0.01% in 2022, then soared by 6264 bps to 0.43% in 2023, then fell by 21 bps to 0.34% in 2024, then jumped by 110 bps to 0.71% in 2025, then sank by 97 bps to 0.02% in 2026.
- Business Quant data shows ALKS's Return on Invested Capital at 0.02% in Q2 2026, 0.71% in Q2 2025, and 0.44% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 0.03% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn | 0.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.02% |
| Jun 30, 2025 | 0.71% |
| Mar 31, 2025 | 0.44% |
| Dec 31, 2024 | 0.34% |
| Sep 30, 2024 | 0.30% |
| Jun 30, 2024 | 0.30% |
| Mar 31, 2024 | 0.46% |
| Dec 31, 2023 | 0.43% |
| Sep 30, 2023 | 0.37% |
| Jun 30, 2023 | 0.25% |
| Mar 31, 2023 | -0.06% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.05% |
| Mar 31, 2022 | 0.07% |
| Dec 31, 2021 | 0.07% |
| Sep 30, 2021 | -0.06% |
| Jun 30, 2021 | -0.06% |
| Mar 31, 2021 | -0.09% |
| Dec 31, 2020 | -0.11% |